Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Technology Update

5 Jun 2007 15:00

ViaLogy PLC05 June 2007 ViaLogy Announces IPv6-capable MicroSPM(TM)for High Definition SurveillanceVideo Processing LONDON, June 5, 2007 -- ViaLogy plc (LSE: VIY), announced today that it hasdeveloped IPv6-capable MicroSPM(TM), compact embedded hardware for highdefinition video processing applications over IP-converged networks. MicroSPM(TM)extends ViaLogy's SPM(TM)software product family by delivering anetwork-centric hardware policy-engine for fully-autonomous incident-based rapiddetection, analysis and response. The MicroSPM(TM)platform addresses threemajor trends within the global surveillance industry: increasing adoption ofnetwork addressable digital video camera and thermal imagers; need for real-timeautonomous processing by moving the policy and the intelligence to the networkedge, and, the accelerated migration to IPv6 addressing standards. MicroSPM(TM)is powered by ViaLogy's proprietary, patented signal processingQuantum Resonance Interferometry ("QRI") technology for detecting weak signalsand image features in high background clutter. QRI delivers video-applicationsin the form of prepackaged user customizable policies in firmware. Initialapplications include: face-extraction in crowds; human, object and vehicledetection and counting, and license plate reading. Immediate verticals includedefense, oil & gas, enterprise safety and security, and, perimeter and bordersurveillance. MicroSPM(TM)enables high speed processing at the video source,only transmitting policy-based exceptions and events to the operator sites. Italso delivers plug-and-play interoperability for IP-enabled video and night-vision devices from different vendors. Today, video surveillance systems are an essential remote monitoring tool forcritical infrastructure, including airports, border crossings, ports, dams,trains and subways; financial and governmental institutions; power grids,utilities and refining facilities. Video is routinely used by businesses formonitoring entrances, walkways, parking lots and warehouses. In banks andretail, surveillance cameras are strategically positioned to monitor and recordthe behavior of customers and tellers. However, the bulk of decision making isperformed by human operators staring at multiple video consoles and manuallycontrolling cameras. Size of this overall video surveillance market is estimatedat over $3 billion for 2007, with sales of security cameras exceeding 6 millionunits and growing at over 30%. According to ViaLogy CTO, Dr. Sandeep Gulati, "Centralized operator-based videoviewing and security decision making is a major choke-point in timely response.Bulk of video is archived and only used for post-incident analysis. MicroSPM'real-time edge processing will significantly expand the actionable informationbandwidth for customers. This is consistent with our focus on broad marketapplications where ViaLogy's QRI signal processing becomes an enabler." ViaLogy President and CEO, Mr. Shah Talukder stated "Customers are facingsignificant challenges in managing a multitude of sensor, video and otherdevices in their networked environments. We see a significant opportunity forscaleable, cost effective and future-proof solutions to manage their global andregional security networks." He added, "We also see MicroSPM(TM)enablingpartners to IPv6-enable their fixed and mobile sensors and network subsystems". Vialogy is in discussions with customers and partners to pilot and deployMicroSPM(TM)within their surveillance infrastructure. For further information please contact: ViaLogyShah Talukder, President & CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.